For: | Raghow R. Betatrophin: A liver-derived hormone for the pancreatic β-cell proliferation. World J Diabetes 2013; 4(6): 234-237 [PMID: 24379912 DOI: 10.4239/wjd.v4.i6.234] |
---|---|
URL: | https://www.wjgnet.com/1948-9358/full/v4/i6/234.htm |
Number | Citing Articles |
1 |
Di Zhang, Yan‑Juan Yu, Feng‑Sen Xu, Jun‑Hua Yuan, Rui Wang, Cai‑Shun Zhang, Liu‑Xin Wang, Yuan Liu, Li‑Min Song, Jun‑Li Liu, Jing Dong. Recombinant betatrophin (Angptl‑8/lipasin) ameliorates streptozotocin‑induced hyperglycemia and β‑cell destruction in neonatal rats. Molecular Medicine Reports 2019; doi: 10.3892/mmr.2019.10719
|
2 |
Bao Q. Lam, Rashmi Srivastava, Jason Morvant, Sharmila Shankar, Rakesh K. Srivastava. Association of Diabetes Mellitus and Alcohol Abuse with Cancer: Molecular Mechanisms and Clinical Significance. Cells 2021; 10(11): 3077 doi: 10.3390/cells10113077
|
3 |
Mohamed Magdy Salama, Walaa Ahmed Kabiel, Silvia Shoukry Hana, Ghada Abdelrahman Mohamed. Correlation of serum betatrophin levels with disease severity and the emergence of insulin resistance in cirrhotic patients. Egyptian Liver Journal 2020; 10(1) doi: 10.1186/s43066-020-00039-7
|
4 |
Jinmi Lee, Seok-Woo Hong, Se Eun Park, Eun-Jung Rhee, Cheol-Young Park, Ki-Won Oh, Sung-Woo Park, Won-Young Lee. AMP-activated protein kinase suppresses the expression of LXR/SREBP-1 signaling-induced ANGPTL8 in HepG2 cells. Molecular and Cellular Endocrinology 2015; 414: 148 doi: 10.1016/j.mce.2015.07.031
|
5 |
Hendra Susanto, Ta-Yu Liu, Chang-Chiang Chen, Jerry D.T. Purnomo, Shu-Fan Chen, Chih-Hong Wang. Increased serum levels of betatrophin in pancreatic cancer-associated diabetes. Oncotarget 2106; 7(27): 42330 doi: 10.18632/oncotarget.9815
|
6 |
Min Yi, Rong-ping Chen, Rui Yang, Xian-feng Guo, Jia-chun Zhang, Hong Chen. Betatrophin Acts as a Diagnostic Biomarker in Type 2 Diabetes Mellitus and Is Negatively Associated with HDL-Cholesterol. International Journal of Endocrinology 2015; 2015: 1 doi: 10.1155/2015/479157
|
7 |
Sanjay Kalra, Saptarshi Bhattacharya, Pawan Rawal. Hepatocrinology. Medical Sciences 2021; 9(2): 39 doi: 10.3390/medsci9020039
|
8 |
|
9 |
Amani Al-Rawashdeh, Violet Kasabri, Nailya Bulatova, Amal Akour, Ayman Zayed, Munther Momani, Nahla Khawaja, Haider Bustanji, Dana Hyasat. The correlation between plasma levels of oxytocin and betatrophin in non-diabetic and diabetic metabolic syndrome patients: A cross sectional study from Jordan. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2017; 11(1): 59 doi: 10.1016/j.dsx.2016.08.008
|
10 |
Zhenjun Zhang, Wenjie Qin, Yuling Sun. Contribution of biomarkers for pancreatic cancer-associated new-onset diabetes to pancreatic cancer screening. Pathology - Research and Practice 2018; 214(12): 1923 doi: 10.1016/j.prp.2018.10.003
|
11 |
Michelle Curran, Mark T. Drayson, Robert C. Andrews, Claudio Zoppi, Jonathan P. Barlow, Thomas P.J. Solomon, Parth Narendran. The benefits of physical exercise for the health of the pancreatic β‐cell: a review of the evidence. Experimental Physiology 2020; 105(4): 579 doi: 10.1113/EP088220
|
12 |
Suna Aydin, Faruk Kilinc, Kader Ugur, Mustafa Ata Aydin, Mehmet Hanifi Yalcin, Tuncay Kuloglu, Nalan Kaya Tektemur, Serdal Albayrak, Elif Emre, Meltem Yardim, Ramazan Fazil Akkoc, Serhat Hancer, İbrahim Sahin, Vedat Cinar, Taner Akbulut, Selcuk Demircan, Bahri Evren, Berrin Tarakci Gencer, Aziz Aksoy, Merve Yilmaz Bozoglan, İsa Aydemir, Suleyman Aydin. Effects of irisin and exercise on adropin and betatrophin in a new metabolic syndrome model. Biotechnic & Histochemistry 2024; 99(1): 21 doi: 10.1080/10520295.2023.2276205
|
13 |
JIN-ZHOU ZHU, CHAO-HUI YU, YOU-MING LI. Betatrophin provides a new insight into diabetes treatment and lipid metabolism (Review). Biomedical Reports 2014; 2(4): 447 doi: 10.3892/br.2014.284
|
14 |
Maria Teresa Arias-Loste, Maria Teresa García-Unzueta, Susana Llerena, Paula Iruzubieta, Angela Puente, Joaquín Cabezas, Carmen Alonso, Antonio Cuadrado, José Antonio Amado, Javier Crespo, Emilio Fábrega. Plasma betatrophin levels in patients with liver cirrhosis. World Journal of Gastroenterology 2015; 21(37): 10662-10668 doi: 10.3748/wjg.v21.i37.10662
|
15 |
Maryam Navaeian, Samieh Asadian, Hossein Ahmadpour Yazdi, Nematollah Gheibi. ANGPTL8 roles in proliferation, metabolic diseases, hypothyroidism, polycystic ovary syndrome, and signaling pathways. Molecular Biology Reports 2021; 48(4): 3719 doi: 10.1007/s11033-021-06270-8
|
16 |
Han Wang, Lin Du, Tong Wu, Gangyi Yang, Wenjing Hu, Hansheng Wang, Mengliu Yang, Dongfang Liu, Harvest F. Gu, Zhiming Zhu, Hongting Zheng, Ling Li. Circulating betatrophin is associated with insulin resistance in humans: cross-sectional and interventional studiesin vivoandin vitro. Oncotarget 2017; 8(57): 96604 doi: 10.18632/oncotarget.21852
|
17 |
Q. Hao, A. Zheng, H. Zhang, H. Cao. Down-regulation of betatrophin enhances insulin sensitivity in type 2 diabetes mellitus through activation of the GSK-3β/PGC-1α signaling pathway. Journal of Endocrinological Investigation 2021; 44(9): 1857 doi: 10.1007/s40618-020-01493-1
|
18 |
Qian Li, Chunmei Li, Jing Jin, Yang Shen, Mei Wang, Weiguo Li. Clinical Significance of Neuregulin 4, Afamin, and SERPINB1 in Gestational Diabetes Mellitus and Their Relationship with Insulin Resistance. Evidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/2829662
|